The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I'm thinking so many jumped on this with way more than they were prepared to loose, thinking it would be a one way journey and be able to ride the momentum wave ever higher. Reality has now set in, and people are bailing or reducing their positions to a more comfortable level hence the sell off
Patience, the foundation are solid, it won't be long before the NHS start adopting their products. Don't forget that the majority if not all of BUPA's consultants day job is for the NHS, so there will be a lot of cross pollination. It could well sell off more in the coming days / weeks, but the momentum on positive RNS is well entrenched and these could easily hit £.
She could have signed up 100 Stalicla deals, it hasn't stopped the share price hitting new lows so in my eyes she has done nothing to add to share holder value.
We are paying Dr Helen Kuhlman all this money and all she can show for her extortionate salary is a small article in some obscure medical journal.
Still, at least some is making money out of Evgen, we're not all losers.
I was hoping any spike would close the 3.02 gap.
Oh well back to drifting lower I suppose.
At least I now know what the coating on the tablet is for.
"The future clinical development of SFX-01 is highly exciting"
But not exciting enough for the bods to dip into their own pockets.
Probably similar to a lot of other holders who got in around the 8p range, currently sitting on a 79% paper loss. You've lost so much already it's hardly worth realizing your loss, he'll stick with it as the only thing left now is hope.
We are bound to get a temporary spike sooner or later.
Tradebot summary today
EVG closed down 2.78 percent on Tuesday, October 17, 2023, on 69 percent of normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
If I were running a business and my share holders were suffering I would be now have a financial vested interest just so I could be seen to be sharing the pain. I wouldn't expect to give out a running daily commentary, but some news with progress or lack of it should be a minimum. Clearly the current bods have no experience of running a business, rabbits in headlights comes to mind.
CJ39 my current position even though it's very small is based on the bods having some integrity, I could be completely wrong and my initial assessment that they are a bunch of charlatans could be more apt. That being the case they won't even bother with a share dilution, they'll just milk the company dry and then shut up shop around this time next year. Huw has a track record of being a director of failed companies. I really think they would struggle to raise new funds as things stand and as you said, it will severely dilute existing shareholders value at these levels.
You may well ask why I've gone in again, apart from the technical analysis 3.02 gap, most holders have lost so much, they won't be selling at these levels so the share price should stabilise.
It's certainly pitch black as things stand.
Well those that listened are greatful as they have minimised their losses. As I said yesterday I'm expecting a small bounce to fill the gap at 3.02p and then I'm out. I'm definitely not encouraging anyone else to buy, or harping on about what a great prospect it is. Short term position to take advantage of it being oversold
Even lower today, 1.849 offer for 10k.
Huw clearly has Viking heritage, he and his fellow board members have definitely pillaged Evgen. The ratio of input (salaries) to output (share price) is boardering on the criminal in my eyes. Still they can't buy for legal reasons, can't wait to see what that advice was and who gave it to them
it will be interesting to see what excuse the bods come up with for not buying during the next q&a.
more than happy to take their extortionate salaries but give back nothing. aim directors at their worst. as a share holder i can now justifiable **** them off.
I'm expecting some kind of bounce so have just purchased 20k shares as a short term position.
Around October 22 I went out with a friend, he noticed that I kept having to go for a wee, and suggested I go for a PSA test. Came out at 4.2, normal reading for someone of my age should have been 3.5. Eventually I got an MRI scan early in January with an option to have a biopsy if that wasn't conclusive. Thankfully the MRI scan was clear but they still gave me the option of an biopsy just to be certain. Having read up on the potential implications I declined, and decided to go for the 3 monthly blood test option instead.
This new test would have saved me 3 months of worry, 4 subsequent trips to my local hospital for blood tests, 2 boarder incursions ( finger up your a--e ) the cost to the NHS associated with this plus the cost of MRI scan. If this is a good as they say it's definitely a game changer.